10-Q: Health In Tech Q1 2026: Revenue Up 9%, Net Loss Widens

Health In Tech reported a 9.4% year-over-year revenue increase to $8.8 million for Q1 2026, driven by its SMR segment, but experienced a widening net loss of $1.6 million.

Summary

• Health In Tech's total revenues for the first quarter of 2026 increased by 9.4% to $8.8 million, up from $8.0 million in the same period of 2025.
• This growth was primarily driven by the SMR segment, which saw a 29.0% increase in revenues, largely due to the launch of its new self-funded plan administration services.
• Conversely, revenues from the ICE segment (underwriting modeling) decreased by 37.6% to $1.5 million.
• The company reported a net loss of $1.6 million for the quarter, a significant increase from a net income of $0.5 million in Q1 2025.
• Adjusted EBITDA also turned negative, falling to a loss of $1.3 million from a positive $1.2 million in the prior year period.
• Cash and cash equivalents increased to $10.3 million, primarily due to a $6.4 million PIPE financing completed in March 2026.
• Accounts receivable saw a substantial increase of $3.0 million, attributed to the new SMR services and revenue growth.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative report due to the significant increase in net loss and negative Adjusted EBITDA, despite revenue growth. The increased operating expenses and negative cash flow from operations are concerning.

Positives

• Total revenues increased by 9.4% year-over-year to $8.8 million.
• SMR segment revenues grew by 29.0% to $7.3 million, driven by new self-funded plan administration services.
• The company completed a $6.4 million PIPE financing in March 2026, bolstering its cash position to $10.3 million.
• Contracted revenue, representing future secured revenue, stood at $22.9 million for the remainder of 2026.
• Platform Placed Plan Value (PPPV) for self-funded stop-loss plans reached $82.0 million in Q1 2026.

Negatives

• Net loss widened significantly to $1.6 million from a net income of $0.5 million in the prior year.
• Adjusted EBITDA turned negative at -$1.3 million, compared to $1.2 million in Q1 2025.
• Cost of revenues increased by 60.3% to $4.3 million and as a percentage of revenue rose to 48.6% from 33.2%.
• Sales and marketing expenses more than doubled to $2.3 million, representing 26.1% of revenue, up from 13.6%.
• ICE segment revenues decreased by 37.6% to $1.5 million.
• Cash used in operating activities was $3.3 million, a reversal from $0.5 million provided in the prior year.

Risks

• The company's growth strategy is heavily reliant on its ability to collaborate with a diverse range of insurance carriers and offer new products and plans.
• Accurate underwriting procedures are critical, and failure to conduct precise actuarial reviews could result in increased costs and reputational harm.
• The company relies on a few primary service providers for its cost of revenues, with one provider accounting for 36.2% of costs in Q1 2026.
• A significant portion of revenue (17.9% in Q1 2026) comes from a single stop-loss insurance carrier, posing concentration risk.
• The company is exposed to risks related to cybersecurity incidents or other network disruptions.
• Risks associated with the use of third-party artificial intelligence are mentioned.
• The company must stay abreast of and comply with new or modified laws and regulations, including data privacy requirements.
• Potential claims relating to intellectual property are a concern.

Future Outlook

The company intends to use the net proceeds from the PIPE financing for sales distribution expansion, technology development, and general corporate purposes. The company believes its existing cash reserves, along with cash generated from operations, will allow it to continue as a going concern for at least the next twelve months.

Management Comments

• "We are dedicated to regularly updating and developing new technology. This continuous investment in technology and innovation will position us at the forefront of the insurance technology."
• "Our growth strategy is heavily reliant on our capability to introduce innovative insurance products and plans. By collaborating with multiple insurance carriers, we can leverage their expertise and resources to develop a broader range of offerings."
• "The Company believes that, if necessary, it could utilize others as part of its service offerings with a limited impact on the Companys operations."

Industry Context

StockSavvy.ai notes that Health In Tech operates in the rapidly evolving Insurtech sector, focusing on simplifying health insurance processes through technology. The company's Q1 2026 results reflect a common industry trend of revenue growth driven by new service offerings, but also highlight the challenges of scaling operations, as evidenced by increased costs and a widening net loss. The reliance on third-party providers and a single major carrier are typical considerations in this space.

Comparison to Industry Standards

• The revenue growth of 9.4% is moderate compared to some high-growth Insurtech startups, but significant given the company's current stage and the increasing complexity of its service offerings.
• The increase in cost of revenues as a percentage of revenue (48.6% vs. 33.2%) suggests potential challenges in operational efficiency or pricing power, which is a key metric for profitability in the Insurtech industry.
• The significant increase in sales and marketing expenses (26.1% of revenue) indicates a strategic push for market penetration, a common approach for companies seeking to capture market share in competitive technology sectors.
• The shift from positive Adjusted EBITDA ($1.2 million) to negative (-$1.3 million) is a concern and warrants close monitoring, as sustained negative EBITDA can strain financial resources, a critical factor for investors in technology companies.

Legal Proceedings

• The company is not presently party to any legal proceedings the resolution of which it believes would have a material adverse effect on its business, prospects, financial condition, liquidity, results of operation, cash flows or capital levels.

Related Party Transactions

• On April 10, 2026, the Company made a cash investment of $428,571 for an 85.7% equity interest in HITChain Inc. The remaining 14.3% is held by the Company's Chief Executive Officer and Chief Financial Officer.
• On April 10, 2026, HITChain granted non-qualified stock options to purchase shares of its Class B common stock to the Company's Chief Executive Officer and Chief Financial Officer (1,000,000 options each).

Stakeholder Impact

• Shareholders: The widening net loss and negative Adjusted EBITDA may negatively impact shareholder value. The PIPE financing dilutes existing shareholders but provides necessary capital for growth.
• Employees: Continued investment in technology and R&D may lead to new opportunities, but the financial performance could impact morale.
• Customers (Employers): The company's new self-funded plan administration services aim to provide streamlined and flexible solutions, potentially benefiting employers.
• Brokers/TPAs/Carriers: The company's platform and services are designed to facilitate their operations, with revenue growth indicating increased activity.
• Creditors: The company's cash position has improved due to the PIPE financing, which should support its ability to meet obligations.

Next Steps

• Utilize net proceeds from the PIPE financing for sales distribution expansion, technology development, and general corporate purposes.
• Continue to develop and enhance technology platforms, including AI-enabled capabilities.
• Expand collaborations with insurance carriers to offer new products and plans.
• Continue to refine underwriting procedures for accuracy and efficiency.
• Monitor and manage relationships with key service providers and insurance carriers.
• Finalize the evaluation of the 'Adjustment' related to a specific carrier's portfolio in May 2026.

Key Dates

Recommendation

While revenue growth is positive, the significant increase in net loss, negative Adjusted EBITDA, and rising operating costs are concerning. The company has secured capital through a PIPE financing, which is a positive, but the path to profitability remains uncertain. A 'hold' recommendation is appropriate pending clearer signs of operational efficiency improvements and a return to profitability.

Keywords

Health In Tech, SEC Filing, 10-Q, Quarterly Report, Insurance Technology, Insurtech, Self-funded Benefits Plans, Stop-loss Insurance, Underwriting, Revenue Growth, Net Loss, PIPE Financing